ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,011 | -9.9% | 1,953,242 | +2.0% | 0.06% | -11.1% |
| Q2 2023 | $58,843 | -16.5% | 1,914,216 | -2.1% | 0.07% | -20.9% |
| Q1 2023 | $70,479 | -28.6% | 1,956,125 | -21.7% | 0.09% | -34.1% |
| Q4 2022 | $98,755 | -99.9% | 2,498,870 | +30.1% | 0.14% | +21.1% |
| Q3 2022 | $77,203,000 | +73.8% | 1,921,426 | +81.9% | 0.11% | +81.0% |
| Q2 2022 | $44,418,000 | +92.4% | 1,056,555 | +78.3% | 0.06% | +117.2% |
| Q1 2022 | $23,083,000 | +976.6% | 592,477 | +898.6% | 0.03% | +866.7% |
| Q3 2021 | $2,144,000 | +174.5% | 59,330 | +231.5% | 0.00% | +200.0% |
| Q1 2021 | $781,000 | -93.7% | 17,900 | -93.9% | 0.00% | -95.0% |
| Q3 2020 | $12,389,000 | – | 294,481 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |